DAWN DEGRASSE: Open Payments
NPI 1255756342 · WEST AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 18 payments from 11 companies in 2025. Trend: 2023 $1,892 · 2024 $1,764 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Amgen Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: SKYRIZI, MOUNJARO, ACTHAR, RINVOQ, SAPHNELO, BENLYSTA, TREMFYA, UPLIZNA.
Industry payments across NY — which companies pay providers there.
